Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1318420Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1419414Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1443240Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1457160Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1468281Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1478275Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1489197Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1503682Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1526741Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1571950Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1579577Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1711727Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1714441Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1949997Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1966261Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2170280Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2188415Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2190551Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2228585Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2259069Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2305575Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2327450Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2385789Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2493975Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2517214Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2527644Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2560915Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2700951Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2884312Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2998979Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+1759280Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+4400587Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+4413215Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+5380901Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+5396116Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+5413091Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+5540730Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+5781374Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+5783493Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+5836791Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+5861981Peak areaPAK Untreated
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+6025213Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+6207770Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+6268148Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+7179219Peak areaHAHA Untreated

Return to search page
  logo